Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

AIMS: With a prevalence of 16%, diabetes mellitus (DM) is one of the most frequent non‐communicable comorbidities of tuberculosis (TB). DM is a major risk factor for adverse TB outcomes and may require personalized TB drug dosing regimens. However, information on the inclusion of DM in TB drug trial...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Clin Pharmacol
Hlavní autoři: Lutfiana, Nurul Cholifah, van Boven, Job F.M., Masoom Zubair, Muhammad Asim, Pena, Michelle J., Alffenaar, Jan‐Willem C.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Systematic Review and Meta‐analysis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595305/
https://ncbi.nlm.nih.gov/pubmed/30908689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13935
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky